COVID: 90% of patients treated with new Israeli drug discharged in 5 days

DM

Some 93% of 90 coronavirus serious patients treated in several Greek hospitals with a new drug developed by a team at Tel Aviv’s Sourasky Medical Center as part of the Phase II trial of the treatment were discharged in five days or fewer. The Phase II trial confirmed the results of Phase I, which was conducted in Israel last winter and saw 29 out of 30 patients in moderate to serious condition recover within days. “The main goal of this study was to verify that the drug is safe,” Prof. Nadir Arber said. “To this day we have not registered any significant side effect in any patient from both groups.”

Notifications - Subscriptions
Notify of
8 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

8
0
Would love your thoughts, please comment.x
()
x